Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202R
Mathi, Gangadhar Rao, Kang, Chung Hyo, Lee, Heung Kyoung, Achary, Raghavendra, Lee, Ha-Yeon, Lee, Joo-Youn, Ha, Jae Du, Ahn, Sunjoo, Park, Chi Hoon, Lee, Chong Ock, Hwang, Jong Yeon, Yun, Chang-Soo, JVolume:
126
Language:
english
Journal:
European Journal of Medicinal Chemistry
DOI:
10.1016/j.ejmech.2016.11.046
Date:
January, 2017
File:
PDF, 1.69 MB
english, 2017